These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 11313946)
1. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth. Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946 [TBL] [Abstract][Full Text] [Related]
2. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018 [TBL] [Abstract][Full Text] [Related]
3. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells. Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316 [TBL] [Abstract][Full Text] [Related]
4. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Deng T; Karin M Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547 [TBL] [Abstract][Full Text] [Related]
5. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator. Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849 [TBL] [Abstract][Full Text] [Related]
6. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat. Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760 [TBL] [Abstract][Full Text] [Related]
7. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation. Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747 [TBL] [Abstract][Full Text] [Related]
8. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling. Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916 [TBL] [Abstract][Full Text] [Related]
9. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets. Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628 [TBL] [Abstract][Full Text] [Related]
10. Human homologue of Drosophila CNK interacts with Ras effector proteins Raf and Rlf. Lanigan TM; Liu A; Huang YZ; Mei L; Margolis B; Guan KL FASEB J; 2003 Nov; 17(14):2048-60. PubMed ID: 14597674 [TBL] [Abstract][Full Text] [Related]
11. Identification of Rgl3 as a potential binding partner for Rap-family small G-proteins and profilin II. Xu J; Shi S; Matsumoto N; Noda M; Kitayama H Cell Signal; 2007 Jul; 19(7):1575-82. PubMed ID: 17382517 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter. Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800 [TBL] [Abstract][Full Text] [Related]
13. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Leevers SJ; Paterson HF; Marshall CJ Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414 [TBL] [Abstract][Full Text] [Related]
15. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways. Hernandez-Muñoz I; Malumbres M; Leonardi P; Pellicer A Oncogene; 2000 May; 19(23):2745-57. PubMed ID: 10851075 [TBL] [Abstract][Full Text] [Related]
17. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153 [TBL] [Abstract][Full Text] [Related]
18. RalGDS family members couple Ras to Ral signalling and that's not all. Ferro E; Trabalzini L Cell Signal; 2010 Dec; 22(12):1804-10. PubMed ID: 20478380 [TBL] [Abstract][Full Text] [Related]
19. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade. Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635 [TBL] [Abstract][Full Text] [Related]
20. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21. Rosário M; Paterson HF; Marshall CJ Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]